ID   Tera-2
AC   CVCL_2777
SY   TERA-2; Tera 2; Tera II
DR   BTO; BTO:0002573
DR   CLO; CLO_0009324
DR   ATCC; HTB-106
DR   Cell_Model_Passport; SIDM01142
DR   Cosmic; 971770
DR   Cosmic; 2816211
DR   DepMap; ACH-001672
DR   Wikidata; Q28248633
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3293662;
RX   PubMed=3518877;
RX   PubMed=6169654;
RX   PubMed=6202829;
RX   PubMed=6244232;
RX   PubMed=6694356;
RX   PubMed=6935474;
RX   PubMed=31500094;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12,13
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 22
//
RX   DOI=10.1007/978-1-4757-1647-4_5;
RA   Fogh J., Trempe G.L.;
RT   "New human tumor cell lines.";
RL   (In) Human tumor cells in vitro; Fogh J. (eds.); pp.115-159; Springer; New York (1975).
//
RX   PubMed=571047;
RA   Fogh J.;
RT   "Cultivation, characterization, and identification of human tumor
RT   cells with emphasis on kidney, testis, and bladder tumors.";
RL   Natl. Cancer Inst. Monogr. 49:5-9(1978).
//
RX   PubMed=833871; DOI=10.1093/jnci/58.2.209;
RA   Fogh J., Wright W.C., Loveless J.D.;
RT   "Absence of HeLa cell contamination in 169 cell lines derived from
RT   human tumors.";
RL   J. Natl. Cancer Inst. 58:209-214(1977).
//
RX   PubMed=3293662; DOI=10.1016/0304-419X(88)90003-0;
RA   Andrews P.W.;
RT   "Human teratocarcinomas.";
RL   Biochim. Biophys. Acta 948:17-36(1988).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=6169654; DOI=10.1002/ijc.2910260304;
RA   Andrews P.W., Bronson D.L., Benham F.J., Strickland S., Knowles B.B.;
RT   "A comparative study of eight cell lines derived from human testicular
RT   teratocarcinoma.";
RL   Int. J. Cancer 26:269-280(1980).
//
RX   PubMed=6202829; DOI=10.1099/0022-1317-65-5-887;
RA   Lower R., Lower J., Frank H., Harzmann R., Kurth R.;
RT   "Human teratocarcinomas cultured in vitro produce unique
RT   retrovirus-like viruses.";
RL   J. Gen. Virol. 65:887-898(1984).
//
RX   PubMed=6244232;
RA   Williams R.D.;
RT   "Human urologic cancer cell lines.";
RL   Invest. Urol. 17:359-363(1980).
//
RX   PubMed=6694356;
RA   Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C.R.,
RA   Dracopoli N.C., Fogh J.;
RT   "Pluripotent embryonal carcinoma clones derived from the human
RT   teratocarcinoma cell line Tera-2. Differentiation in vivo and in
RT   vitro.";
RL   Lab. Invest. 50:147-162(1984).
//
RX   PubMed=6935474; DOI=10.1093/jnci/66.2.239;
RA   Wright W.C., Daniels W.P., Fogh J.;
RT   "Distinction of seventy-one cultured human tumor cell lines by
RT   polymorphic enzyme analysis.";
RL   J. Natl. Cancer Inst. 66:239-247(1981).
//
RX   PubMed=31500094; DOI=10.3390/cancers11091316;
RA   Bakardjieva-Mihaylova V., Skvarova Kramarzova K., Slamova M.,
RA   Svaton M., Rejlova K., Zaliova M., Dobiasova A., Fiser K., Stuchly J.,
RA   Grega M., Rosova B., Zachoval R., Klezl P., Eis V., Kindlova E.,
RA   Buchler T., Trka J., Boublikova L.;
RT   "Molecular basis of cisplatin resistance in testicular germ cell
RT   tumors.";
RL   Cancers (Basel) 11:1316.1-1316.18(2019).
//